MEDINET Co., Ltd. (2370.T)
JPY 32.0
(0.0%)
JPY 32.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -4.39 Billion JPY | 2.24% |
| 2022 | -4.49 Billion JPY | -9.95% |
| 2021 | -4.08 Billion JPY | -12.7% |
| 2020 | -3.62 Billion JPY | -164.63% |
| 2019 | -1.37 Billion JPY | 35.6% |
| 2018 | -2.12 Billion JPY | 11.65% |
| 2017 | -2.4 Billion JPY | -65.42% |
| 2016 | -1.45 Billion JPY | -20.34% |
| 2015 | -1.21 Billion JPY | 1.79% |
| 2014 | -1.23 Billion JPY | -1.76% |
| 2013 | -1.21 Billion JPY | -468.51% |
| 2012 | 328.59 Million JPY | 4904.48% |
| 2011 | 6.56 Million JPY | 100.34% |
| 2010 | -1.93 Billion JPY | -39.44% |
| 2009 | -1.38 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -4.59 Billion JPY | 4.68% |
| 2024 Q1 | -4.94 Billion JPY | -12.47% |
| 2024 Q2 | -4.81 Billion JPY | 2.55% |
| 2023 Q2 | -3.93 Billion JPY | 2.86% |
| 2023 Q3 | -3.92 Billion JPY | 0.34% |
| 2023 Q4 | -4.39 Billion JPY | -11.94% |
| 2023 Q1 | -4.05 Billion JPY | 9.78% |
| 2023 FY | -4.39 Billion JPY | 2.24% |
| 2022 Q1 | -4.07 Billion JPY | 0.34% |
| 2022 FY | -4.49 Billion JPY | -9.95% |
| 2022 Q4 | -4.49 Billion JPY | 3.71% |
| 2022 Q3 | -4.66 Billion JPY | -13.97% |
| 2022 Q2 | -4.09 Billion JPY | -0.53% |
| 2021 Q1 | -4.06 Billion JPY | -11.99% |
| 2021 FY | -4.08 Billion JPY | -12.7% |
| 2021 Q4 | -4.08 Billion JPY | 2.59% |
| 2021 Q3 | -4.19 Billion JPY | -4.4% |
| 2021 Q2 | -4.01 Billion JPY | 1.04% |
| 2020 Q4 | -3.62 Billion JPY | -66.71% |
| 2020 FY | -3.62 Billion JPY | -164.63% |
| 2020 Q2 | -1.66 Billion JPY | -7.38% |
| 2020 Q3 | -2.17 Billion JPY | -30.78% |
| 2020 Q1 | -1.54 Billion JPY | -13.04% |
| 2019 Q1 | -1.94 Billion JPY | 8.52% |
| 2019 Q4 | -1.37 Billion JPY | -31.66% |
| 2019 Q3 | -1.04 Billion JPY | 22.93% |
| 2019 Q2 | -1.35 Billion JPY | 30.61% |
| 2019 FY | -1.37 Billion JPY | 35.6% |
| 2018 Q4 | -2.12 Billion JPY | 16.86% |
| 2018 Q3 | -2.55 Billion JPY | 6.77% |
| 2018 Q2 | -2.74 Billion JPY | 21.44% |
| 2018 Q1 | -3.49 Billion JPY | -45.1% |
| 2018 FY | -2.12 Billion JPY | 11.65% |
| 2017 Q4 | -2.4 Billion JPY | -115.85% |
| 2017 Q2 | -1.16 Billion JPY | -1.78% |
| 2017 Q3 | -1.11 Billion JPY | 3.84% |
| 2017 FY | -2.4 Billion JPY | -65.42% |
| 2017 Q1 | -1.14 Billion JPY | 21.69% |
| 2016 Q1 | -1.04 Billion JPY | 13.5% |
| 2016 Q2 | -765.83 Million JPY | 26.83% |
| 2016 Q3 | -1.11 Billion JPY | -46.23% |
| 2016 Q4 | -1.45 Billion JPY | -30.04% |
| 2016 FY | -1.45 Billion JPY | -20.34% |
| 2015 FY | -1.21 Billion JPY | 1.79% |
| 2015 Q2 | -1.06 Billion JPY | 37.19% |
| 2015 Q1 | -1.68 Billion JPY | -36.97% |
| 2015 Q4 | -1.21 Billion JPY | 31.89% |
| 2015 Q3 | -1.77 Billion JPY | -67.6% |
| 2014 Q3 | -1.66 Billion JPY | 18.44% |
| 2014 Q2 | -2.04 Billion JPY | -4640.46% |
| 2014 Q1 | -43.15 Million JPY | 96.44% |
| 2014 FY | -1.23 Billion JPY | -1.76% |
| 2014 Q4 | -1.23 Billion JPY | 26.15% |
| 2013 Q2 | -473.43 Million JPY | -185.12% |
| 2013 Q3 | -687.85 Million JPY | -45.29% |
| 2013 Q4 | -1.21 Billion JPY | -76.04% |
| 2013 FY | -1.21 Billion JPY | -468.51% |
| 2013 Q1 | 556.21 Million JPY | 69.27% |
| 2012 Q3 | 455.44 Million JPY | 169.6% |
| 2012 Q4 | 328.59 Million JPY | -27.85% |
| 2012 FY | 328.59 Million JPY | 4904.48% |
| 2012 Q1 | 418.33 Million JPY | 6271.18% |
| 2012 Q2 | 168.93 Million JPY | -59.62% |
| 2011 FY | 6.56 Million JPY | 100.34% |
| 2011 Q1 | -2.14 Billion JPY | -10.84% |
| 2011 Q2 | -847.04 Million JPY | 60.52% |
| 2011 Q3 | -288.38 Million JPY | 65.95% |
| 2011 Q4 | 6.56 Million JPY | 102.28% |
| 2010 Q1 | -1.48 Billion JPY | -6.8% |
| 2010 Q2 | -1.52 Billion JPY | -2.72% |
| 2010 FY | -1.93 Billion JPY | -39.44% |
| 2010 Q4 | -1.93 Billion JPY | -5269.19% |
| 2010 Q3 | 37.45 Million JPY | 102.46% |
| 2009 FY | -1.38 Billion JPY | 0.0% |
| 2009 Q2 | -748.14 Million JPY | 17.07% |
| 2009 Q4 | -1.38 Billion JPY | 0.0% |
| 2009 Q1 | -902.09 Million JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 742.75 Million JPY | 691.582% |
| PRISM BioLab Co.,LTD | -1.13 Billion JPY | -287.5% |
| GNI Group Ltd. | -17.93 Billion JPY | 75.498% |
| Linical Co., Ltd. | -4.46 Billion JPY | 1.552% |
| Trans Genic Inc. | -221.16 Million JPY | -1886.728% |
| Soiken Holdings Inc. | -4.79 Billion JPY | 8.267% |
| Cytori Cell Research Institute, Inc. | 1.43 Billion JPY | 406.516% |
| AnGes, Inc. | -3.79 Billion JPY | -15.701% |
| OncoTherapy Science, Inc. | -420.8 Million JPY | -944.19% |
| Nxera Pharma Co., Ltd. | 24.9 Billion JPY | 117.641% |
| Immuno-Biological Laboratories Co., Ltd. | -498.15 Million JPY | -782.062% |
| NanoCarrier Co., Ltd. | -466.34 Million JPY | -842.222% |
| Carna Biosciences, Inc. | -2.7 Billion JPY | -62.373% |
| CanBas Co., Ltd. | -1.88 Billion JPY | -132.71% |
| D. Western Therapeutics Institute, Inc. | -982.14 Million JPY | -347.392% |
| RaQualia Pharma Inc. | -3.39 Billion JPY | -29.349% |
| Chiome Bioscience Inc. | -1.03 Billion JPY | -324.727% |
| Kidswell Bio Corporation | 343.58 Million JPY | 1378.861% |
| PeptiDream Inc. | 3.29 Billion JPY | 233.476% |
| Oncolys BioPharma Inc. | -972.59 Million JPY | -351.785% |
| Ribomic Inc. | -2.09 Billion JPY | -109.265% |
| SanBio Company Limited | -3.78 Billion JPY | -15.946% |
| Healios K.K. | -2.19 Billion JPY | -100.64% |
| BrightPath Biotherapeutics Co., Ltd. | -944.85 Million JPY | -365.045% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -2.62 Billion JPY | -67.446% |
| Delta-Fly Pharma, Inc. | -1.41 Billion JPY | -210.08% |
| StemRIM | -8.41 Billion JPY | 47.752% |
| CellSource Co., Ltd. | -4.68 Billion JPY | 6.18% |
| FunPep Company Limited | -1.79 Billion JPY | -145.014% |
| Kringle Pharma, Inc. | -2.13 Billion JPY | -105.666% |
| Stella Pharma Corporation | -1.11 Billion JPY | -292.533% |
| TMS Co., Ltd. | -3.44 Billion JPY | -27.488% |
| Noile-Immune Biotech Inc. | -5.55 Billion JPY | 20.909% |
| Cuorips Inc. | -5.56 Billion JPY | 20.985% |
| K Pharma,Inc. | -3.26 Billion JPY | -34.522% |
| Takara Bio Inc. | -32.2 Billion JPY | 86.355% |
| ReproCELL Incorporated | -2.93 Billion JPY | -49.505% |
| PhoenixBio Co., Ltd. | -660.96 Million JPY | -564.795% |
| StemCell Institute Inc. | -2.83 Billion JPY | -54.896% |
| Japan Tissue Engineering Co., Ltd. | -2.06 Billion JPY | -112.647% |
| CellSeed Inc. | -2.01 Billion JPY | -118.386% |